Grant: Master's Award: Canada Graduate Scholarships
University of Alberta
$17,500.00
The Regulation of p53 Through Site-Specific Dephosphorylation
EF 2015-16
Résumé
Roughly 40% of Canadians will be diagnosed with cancer during their lifetime, based on the 2015 Canadian Cancer Statistics projection by the Canadian Cancer Society. Although the term cancer encompasses a broad range of distinctive diseases, one protein in particular has been called the common denominator among most human cancers: p53. Through its interaction with an array of proteins, p53 determines whether a cell should live or die. The inhibitory Apoptotic Stimulating Protein of p53 (iASPP) is found in high levels in several types of cancers and inhibits p53's ability to kill cancerous cells; however, it is unknown how iASPP does this at a molecular level. p53 contains many sites that can be tagged with a phosphate (i.e. phosphorylated) which allows it to interact with specific proteins to cause cell death. Recently, Protein Phosphatase 1 (PP1) was found to interact with iASPP and p53, where iASPP forms a bridge between PP1 and p53. PP1 is capable of removing phosphate groups from proteins and therefor it is likely that iASPP guides PP1 to remove the phosphates on p53, effectively preventing the interaction of p53 with cell death promoting proteins. Therefor, small molecules that inhibit the interaction of these three proteins may serve as valuable chemotherapeutics, however further knowledge is needed about the specific interactions between PP1, iASPP and p53 function. Thus, the goal of this research project is to identify the sites on p53 that are dephosphorylated by the PP1/iASPP interaction, and further, to identify the specific regions on the iASPP protein that are necessary for interacting with PP1 and p53. These studies will map the regions of iASPP that should be targeted in the design of novel and targeted chemotherapeutics.<span style=font-size: 12.8px; line-height: 1.5em;>
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
350110
Name
Millott Robyn A
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The Regulation of p53 Through Site-Specific Dephosphorylation
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer; Dephosphorylation; Phosphatases; Protein Biochemistry; Transcription Factor Regulation
Abstract
Roughly 40% of Canadians will be diagnosed with cancer during their lifetime, based on the 2015 Canadian Cancer Statistics projection by the Canadian Cancer Society. Although the term cancer encompasses a broad range of distinctive diseases, one protein in particular has been called the common denominator among most human cancers: p53. Through its interaction with an array of proteins, p53 determines whether a cell should live or die. The inhibitory Apoptotic Stimulating Protein of p53 (iASPP) is found in high levels in several types of cancers and inhibits p53's ability to kill cancerous cells; however, it is unknown how iASPP does this at a molecular level. p53 contains many sites that can be tagged with a phosphate (i.e. phosphorylated) which allows it to interact with specific proteins to cause cell death. Recently, Protein Phosphatase 1 (PP1) was found to interact with iASPP and p53, where iASPP forms a bridge between PP1 and p53. PP1 is capable of removing phosphate groups from proteins and therefor it is likely that iASPP guides PP1 to remove the phosphates on p53, effectively preventing the interaction of p53 with cell death promoting proteins. Therefor, small molecules that inhibit the interaction of these three proteins may serve as valuable chemotherapeutics, however further knowledge is needed about the specific interactions between PP1, iASPP and p53 function. Thus, the goal of this research project is to identify the sites on p53 that are dephosphorylated by the PP1/iASPP interaction, and further, to identify the specific regions on the iASPP protein that are necessary for interacting with PP1 and p53. These studies will map the regions of iASPP that should be targeted in the design of novel and targeted chemotherapeutics.<span style=font-size: 12.8px; line-height: 1.5em;>
Competitiondate
201512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Millott, Robyn A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~